Bdr Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 15-11-2024
- Paid Up Capital ₹ 4.29 Cr
as on 15-11-2024
- Company Age 31 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 8.65 Cr
as on 15-11-2024
- Revenue -47.76%
(FY 2023)
- Profit -64.68%
(FY 2023)
- Ebitda -76.62%
(FY 2023)
- Net Worth 13.56%
(FY 2023)
- Total Assets 11.26%
(FY 2023)
About Bdr Lifesciences
The Corporate was formerly known as Macrolide Anitibiotics Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 4.29 Cr.
The company has closed loans amounting to ₹8.65 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Sanjay Solanki, Tejash Shah, Ketan Shah, and Three other members serve as directors at the Company.
- CIN/LLPIN
U24230GJ1993PTC020258
- Company No.
020258
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Sep 1993
- Date of AGM
27 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Bdr Lifesciences?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Tejash Shah  | Director | 19-Apr-2021 | Current |
| Raheel Shah | Director | 29-Jul-2011 | Current |
| Sanjay Solanki | Director | 12-Dec-2009 | Current |
| Ketan Shah | Director | 05-Jul-2010 | Current |
| Trushit Mehta | Director | 01-Nov-2012 | Current |
| Dheer Shah | Director | 30-May-2018 | Current |
Financial Performance of Bdr Lifesciences.
Bdr Lifesciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 47.76% decrease. The company also saw a substantial fall in profitability, with a 64.68% decrease in profit. The company's net worth Soared by an impressive increase of 13.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bdr Lifesciences?
In 2023, Bdr Lifesciences had a promoter holding of 89.48% and a public holding of 10.51%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Spinos Life Science And Research Private LimitedActive 8 years 8 monthsRaheel Shah and Dheer Shah are mutual person
Virdev Intermediates Private LimitedActive 30 years 10 monthsSanjay Solanki, Raheel Shah and 1 more are mutual person
- Bdr Pharmaceuticals International Private LimitedActive 22 years 2 months
Tejash Shah and Raheel Shah are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Idbi Bank Ltd. Creation Date: 03 Mar 1999 | ₹8.65 Cr | Satisfied |
How Many Employees Work at Bdr Lifesciences?
Bdr Lifesciences has a workforce of 263 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bdr Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bdr Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
